Silo Pharma Launches Ibogaine-Based TBI Therapeutics Initiative Amid Growing Federal Support for Psychedelic Medicine Innovation

New initiative from Silo Pharma designed to align with federal actions to accelerate mental health innovation using psychedelic medicines Silo Pharma ta...

May 08, 2026 | Friday | News
arcoris bio Launches immunoMUSE® Kits to Advance Custom Multiplex Biomarker Detection

arcoris bio, a Swiss life science research tools and in vitro diagnostics company, today announced the launch of its immunoMUSE® kits, based on its ...

May 07, 2026 | Thursday | News
Lunai Bioworks Expands CNS Platform with $20 Million IP Acquisition to Advance Alzheimer’s and Neurotherapeutic Programs

Transaction Adds Dual BBB Delivery Strategies, Supports Alzheimer's Programs, Combination Therapies, 505(b)(2) Pathways, and CNS Countermeasure Applicati...

May 06, 2026 | Wednesday | News
Advancing Precision Radiotherapeutics for Hard-to-Treat CNS Cancers

  Central nervous system (CNS) cancers remain among the most difficult diseases to treat in oncology, with limited therapeutic options, complex deliv...

May 04, 2026 | Monday | Interaction
Turning Clinical Complexity into Predictive Intelligence: How BullFrog AI Is Redefining Drug Development

As pharmaceutical companies continue to face high attrition rates, rising development costs and increasingly complex clinical datasets, the industry is sea...

May 04, 2026 | Monday | Interview
Cleaning Beyond Compliance: How Biopharma Manufacturers Can Unlock Capacity Through Smarter Contamination Control

  As biologics manufacturing operations become increasingly complex, biopharma companies are under growing pressure to improve efficiency, strengthen...

May 04, 2026 | Monday | Interaction
LTS LOHMANN Therapie-Systeme AG Expands CDMO Portfolio with U.S.-Based Ophthalmic Drug Delivery Services

LTS LOHMANN Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company specializing in advanced drug delivery systems, announced the expans...

April 01, 2026 | Wednesday | News
TrialClinIQ Secures Pre-Seed Funding and Accelerator Backing to Advance Equitable Clinical Trial Access

TrialClinIQ, an AI-powered clinical trial recruitment platform based in Houston, Texas advancing health equity, announced a $150K pre-seed investment fro...

April 30, 2026 | Thursday | News
Thermo Fisher Scientific Opens Flagship Bioprocess Design Center in Massachusetts to Accelerate Biologics Development

  Expansion of Plainville, Mass., facility offers bioprocessing expertise, advanced technologies and customized support Thermo Fisher Scientific Inc...

April 29, 2026 | Wednesday | News
Novartis Secures EU Approval for Rhapsido® (Remibrutinib), First Oral Targeted Therapy for Chronic Spontaneous Urticaria

Significant improvements as early as Week 1, favorable safety profile and no liver safety concerns in REMIX 1 & 2 studies ...

April 28, 2026 | Tuesday | News
OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation for Pegrizeprument (VEL-101) in Heart Transplant Rejection Prevention

OSE Immunotherapeutics SA  welcomes the announcement by its partner Veloxis Pharmaceuticals, Inc. that the U.S. Food and Drug Administration (FDA) h...

April 28, 2026 | Tuesday | News
Mabwell Advances First Nectin-4 ADC into Phase III for TNBC with 9MW2821

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announces the initiation of a Phase III clini...

April 27, 2026 | Monday | News
Servier Completes $2.5B Acquisition of Day One Biopharmaceuticals, Bolstering Rare Cancer Pipeline with OJEMDA

Acquisition expands Servier's position in oncology with tovorafenib marketed as OJEMDATM in the U.S. in pediatric low-grade gl...

April 27, 2026 | Monday | News
AbbVie Confident in Rapid Path Forward After U.S. Food and Drug Administration Flags Manufacturing Issues in TrenibotE Review

U.S. Food and Drug Administration (FDA) issues Complete Response Letter (CRL) for trenibotulinumtoxinE (TrenibotE) related to manufacturing processes; ...

April 27, 2026 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close